Enanta Pharmaceuticals Investor Relations Material
Latest events
Study Result
Enanta Pharmaceuticals
Corporate Presentation
3 Sep, 2025
Q3 2025
11 Aug, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Enanta Pharmaceuticals Inc
Access all reports
Enanta Pharmaceuticals Inc is a biotechnology company focused on the research and development of small molecule drugs targeting viral infections and liver diseases. It specializes in therapies for hepatitis, respiratory infections, and other viral illnesses. The company is headquartered in Watertown, Massachusetts, and its shares are listed on the NASDAQ.
Key slides for Enanta Pharmaceuticals Inc
43rd Annual J.P. Morgan Healthcare Conference 2025
Enanta Pharmaceuticals Inc
43rd Annual J.P. Morgan Healthcare Conference 2025
Enanta Pharmaceuticals Inc
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
ENTA
Country
🇺🇸 United States